Alzamend Neuro, Inc. Quarterly Return On Equity in % from Q2 2023 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Alzamend Neuro, Inc. quarterly/annual Return On Equity history and growth rate from Q2 2023 to Q2 2024.
  • Alzamend Neuro, Inc. Return On Equity for the quarter ending July 31, 2024 was 275 %.
  • Alzamend Neuro, Inc. annual Return On Equity for 2023 was -138 %, a 24.3% decline from 2022.
  • Alzamend Neuro, Inc. annual Return On Equity for 2022 was -111 %, a 99.8% increase from 2021.
Return On Equity, Quarterly (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 275 +625 May 1, 2024 Jul 31, 2024
Q1 2024 412 Feb 1, 2024 Apr 30, 2024
Q4 2023 1.24K Nov 1, 2023 Jan 31, 2024
Q3 2023 -993 Aug 1, 2023 Oct 31, 2023
Q2 2023 -350 May 1, 2023 Jul 31, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.